Clinical trial
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell…
NCT00030589 · Millennix, Industry · Unknown status
Key facts
| NCT number | NCT00030589 |
|---|---|
| Title | Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma |
| Official title | A Muliticenter, Dose-Reandomized Evaluation Of Targretin Capsules Plus PUVA In Patients With Stage IB - IIA Cutaneous T-Cell Lymphoma |
| Lead sponsor | Millennix, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | bexarotene, methoxsalen, UV light therapy |
| Start date | Feb 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: